Immunofluorescence (IF) analyses showed that while PAR-2 was expressed in epithelial cells and the cellular matrix from both pancreatic cancer and control specimens, PAR-2 levels were increased in pancreatic cancer (Figure 1C). This evidence concerns the gene F2RL1 and familial pancreatic carcinoma.